Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000078003-15-000046
Filing Date
2015-10-23
Accepted
2015-10-23 15:46:24
Documents
2
Group Members
C. P. PHARMACEUTICALS INTERNATIONAL C.V.PFIZER MANUFACTURING LLCPFIZER PRODUCTION LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G 2pro3g.htm SC 13G 14736
2 EXHIBIT 99.1 nex1pro.htm EX-99.1 2432
  Complete submission text file 0000078003-15-000046.txt   19144
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 151172902
SIC: 2836 Biological Products, (No Diagnostic Substances)